Xulane Interactions
There are 456 drugs known to interact with Xulane (ethinyl estradiol/norelgestromin), along with 18 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 50 are major, 360 are moderate, and 46 are minor.
- View all 456 medications that may interact with Xulane
- View Xulane alcohol/food interactions (4)
- View Xulane disease interactions (18)
Most frequently checked interactions
View interaction reports for Xulane (ethinyl estradiol / norelgestromin) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- amitriptyline
- bupropion
- buspirone
- cetirizine
- doxycycline
- Flonase (fluticasone nasal)
- gabapentin
- hydroxyzine
- ibuprofen
- Lexapro (escitalopram)
- melatonin
- meloxicam
- montelukast
- omeprazole
- ondansetron
- pantoprazole
- prednisone
- propranolol
- sertraline
- sumatriptan
- tizanidine
- topiramate
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Xulane alcohol/food interactions
There are 4 alcohol/food interactions with Xulane (ethinyl estradiol / norelgestromin).
Xulane disease interactions
There are 18 disease interactions with Xulane (ethinyl estradiol / norelgestromin) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Xulane (ethinyl estradiol / norelgestromin)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.